Kailera Therapeutics · 7 hours ago
Associate Director, CMC Operations
Kailera is committed to developing therapies that empower individuals to transform their lives and enhance their health. The Associate Director, CMC Operations will manage CMC activities, including financial management, alliance management, and regulatory submissions, while collaborating with cross-functional teams to support multiple development projects.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Support execution of CMC-related projects, culminating in the successful preparation of regulatory submissions and product approvals
Actively support Tech Ops strategies and goals by participating in and/or leading cross-functional CMC sub-teams
Work closely and collaboratively with Tech Ops, Quality, Regulatory, and Finance colleagues to maintain highly efficient practices for pharmaceutical product development and budget management activities
Proactively communicate key issues and any other critical topics in a timely manner to the appropriate management level and/or to any other relevant project team members
Ensure quality, quantity, and timelines in all assigned projects
Update team members on project target dates and priorities. Proactively contributes to budget forecasts and tracking expenses
Qualification
Required
10+ years of experience in pharmaceutical drug development, clinical and/or commercial manufacturing familiarity, and track record of success supporting multiple projects or programs simultaneously
Excellent communication/presentation skills and proficiency in Smartsheet software
Proven track record of creativity, problem solving, and productivity, particularly when no or minimal precedent is in place
Demonstrated successful experience with working in interdisciplinary and cross-cultural teams
Preferred
Bachelor's degree in a scientific discipline
Benefits
Comprehensive health coverage
Flexible time off
Paid holidays
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Leadership Team
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase